期刊文献+

脂质肉芽肿病诊断及治疗进展 被引量:1

Diagnosis and Treatment of Erdheim-Chester Disease——Review
下载PDF
导出
摘要 肉芽肿病(Erdheim-Chester Disease,ECD)是一种罕见的非朗格汉斯细胞组织细胞增生症,其病因和发病机制仍然不清,以富含脂质的泡沫细胞侵犯骨骼及多种器官为特征。无特异性临床表现,可从局部病变到危及生命的器官衰竭。本文对ECD的发病机制、临床表现、诊断标准和治疗作一综述。 Erdheim-Chester Disease(ECD) is a rare form of non Langerhans’ cell histiocytosis.The etiology of ECD is unknown yet.The disease is characterized by the infiltration of lipid-laden histiocytes with foamy to bones and various organs.The heterogeneous manifestations of ECD vary among different individuals.This results in a presentation that may vary from an indolent focal disease to a life threatening organ failure.This review focuses on the etiology,clinical presentation,diagnostic criteria and treatment of Erdheim-Chester disease(ECD).
作者 王晶石 王昭
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第4期1256-1259,共4页 Journal of Experimental Hematology
关键词 脂质肉芽肿病 非朗格汉斯细胞组织细胞增生症 诊断 治疗 Erdheim-Chester Disease non Langerhans’ cell histiocvtosis diagnosis treatment
  • 相关文献

参考文献26

  • 1Mazor RD,Manevich-Mazor M,Shoenfeld Y.Erdheim-Chester Disease:a comprehensive review of the Literature. Orphanet J Rare Dis . 2013
  • 2Lorenzo Dagna,Angelo Corti,Silvia Langheim.Tumor Necrosis Factor alpha As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab. Journal of Clinical Oncology . 2012
  • 3Myra C,Sloper L,Tighe P J,McIntosh R S,Stevens S E,Gregson R H S,Sokal M,Haynes A P,Powell R J.Treatment of Erdheim-Chester disease with cladribine: a rational approach. The British journal of ophthalmology . 2004
  • 4Emile JF,Charlotte F,Amoura Z,et al.BRAF mutations in Erdheim-Chester disease. Journal of Clinical Oncology . 2013
  • 5Dion Elisabeth,Graef Claire,Miquel Anne,Haroche Julien,Wechsler Bertrand,Amoura Zahir,Zeitoun Delphine,Grenier Philippe A,Piette Jean-Claude,Laredo Jean-Denis.Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology . 2005
  • 6Arnaud Laurent,Hervier Baptiste,Néel Antoine,Hamidou Mohamed A,Kahn Jean-Emmanuel,Wechsler Bertrand,Pérez-Pastor Gemma,Blomberg Bj?rn,Fuzibet Jean-Gabriel,Dubourguet Fran?ois,Marinho António,Magnette Catherine,Noel Violaine,Pavic Michel,C.CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood . 2011
  • 7Aouba Achille,Georgin-Lavialle Sophie,Pagnoux Christian,Martin Silva Nicolas,Renand Amédée,Galateau-Salle Fran?oise,Le Toquin Sophie,Bensadoun Henri,Larousserie Frederique,Silvera Stéphane,Provost Nicole,Candon Sophie,Seror Raphaèle,de Me.Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood . 2010
  • 8Badalian-Very Gayane,Vergilio Jo-Anne,Degar Barbara A,MacConaill Laura E,Brandner Barbara,Calicchio Monica L,Kuo Frank C,Ligon Azra H,Stevenson Kristen E,Kehoe Sarah M,Garraway Levi A,Hahn William C,Meyerson Matthew,Fleming Mark D,Rollins Ba.Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood . 2010
  • 9Haroche J,Cohen-Aubart F,Emile JF,et al.Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood . 2013
  • 10Berti A,Ferrarini M,Ferrero E,et al.Cardiovascular manifestations of Erdheim-Chester disease. Clinical and Experimental Rheumatology . 2015

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部